NCT05233982View on ClinicalTrials.gov

MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Ovarian Cancer
Interventions
DRUG

Olaparib Oral Product

Olaparib Maintenace Treatment after first line platium based chemotherapy in BRCA wilde-type ovarian cancer patients

Trial Locations (5)

80131

RECRUITING

IRCCS Istituto Nazionale Tumori di Napoli, Naples

Unknown

NOT_YET_RECRUITING

ONCOLOGIA MEDICA A.O. S. Giuseppe Moscati, Avellino

NOT_YET_RECRUITING

U.O.C. Oncologia Medica - Ospedale Senatore Antonio Perrino, Brindisi

NOT_YET_RECRUITING

"Oncologia Medica 2 - Istituto Nazionale Tumori Regina Elena", Roma

NOT_YET_RECRUITING

ONCOLOGIA MEDICA 1 Istituto Nazionale Tumori Regina Elena - IRCCS - IFO, Rome

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER